Real-World Deutetrabenazine Dosing Patterns in Patients With Huntington's Disease or Tardive Dyskinesia

被引：0
|
作者：
Ayyagari, R. [1 ]
Wilhelm, A. [1 ]
Alexander, J. [1 ]
Chaijale, N. [1 ]
Garcia-Horton, V. [1 ]
Devine, F. [1 ]
Carroll, B. [1 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
76
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] Deutetrabenazine (Austedo) for Huntington's Chorea and Tardive Dyskinesia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1545): : 65 - 68
  • [2] Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington's Disease
    Claassen, Daniel O.
    Ayyagari, Rajeev
    Garcia-Horton, Viviana
    Zhang, Su
    Alexander, Jessica
    Leo, Sam
    NEUROLOGY, 2021, 96 (15)
  • [3] Real-World Experience With Deutetrabenazine for Huntington Disease Chorea
    Curtis, Kendall
    Sung, Victor
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (02): : 178 - 181
  • [4] Predictors of persistence to deutetrabenazine among patients with tardive dyskinesia (TD) and Huntington's disease (HD)
    Claassen, D.
    Ayyagari, R.
    Garcia-Horton, V.
    Zhang, S.
    Leo, S.
    MOVEMENT DISORDERS, 2021, 36 : S30 - S31
  • [5] Real-world effectiveness and safety of deutetrabenazine in patients with chorea associated with Huntington disease
    Sung, V.
    White, A.
    Romdhani, H.
    Goldschmidt, D.
    Ayyagari, R.
    Chaijale, N.
    Yaari, A.
    Gordon, M.
    Logan, J.
    Yang, A.
    Ribalov, R.
    MOVEMENT DISORDERS, 2023, 38 : S401 - S401
  • [6] Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease
    Frank, Samuel
    Anderson, Karen E.
    Fernandez, Hubert H.
    Hauser, Robert A.
    Claassen, Daniel O.
    Stamler, David
    Factor, Stewart A.
    Jimenez-Shahed, Joohi
    Barkay, Hadas
    Wilhelm, Amanda
    Alexander, Jessica K.
    Chaijale, Nayla
    Barash, Steve
    Savola, Juha-Matti
    Gordon, Mark Forrest
    Chen, Maria
    NEUROLOGY AND THERAPY, 2024, 13 (03) : 655 - 675
  • [7] Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome
    Paton, D. M.
    DRUGS OF TODAY, 2017, 53 (02) : 89 - 102
  • [8] Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis
    Daniel O. Claassen
    Rajeev Ayyagari
    Viviana Garcia-Horton
    Su Zhang
    Jessica Alexander
    Sam Leo
    Neurology and Therapy, 2022, 11 : 435 - 448
  • [9] Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia
    Frank, Samuel
    Alakkas, Aljoharah
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 1019 - 1024
  • [10] Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington?s disease: a review of clinical trial data
    Claassen, Daniel O.
    Philbin, Michael
    Carroll, Benjamin
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (18) : 2209 - 2221
12345